AIMS: Hyperglycaemia (HG) decreases intracellular tetrahydrobiopterin (BH(4)) concentrations, and this action may contribute to injury during myocardial ischaemia and reperfusion. We investigated whether increased BH(4) by cardiomyocyte-specific overexpression of the GTP cyclohydrolase (GTPCH) 1 gene rescues myocardial and mitochondrial protection by ischaemic preconditioning (IPC) during HG through a nitric oxide (NO)-dependent pathway. METHODS AND RESULTS: Mice underwent 30 min of myocardial ischaemia followed by 2 h of reperfusion with or without IPC elicited with four cycles of 5 min ischaemia/5 min of reperfusion in the presence or absence of HG produced by d-glucose. In C57BL/6 wild-type mice, IPC increased myocardial BH(4) and NO concentrations and decreased myocardial infarct size (30 ± 3% of risk area) compared with control (56 ± 5%) experiments. This protective effect was inhibited by HG (48 ± 3%) but not hyperosmolarity. GTPCH-1 overexpression increased myocardial BH(4) and NO concentrations and restored cardioprotection by IPC during HG (32 ± 4%). In contrast, a non-selective NO synthase inhibitor N(G)-nitro-l-arginine methyl ester attenuated the favourable effects of GTPCH-1 overexpression (52 ± 3%) during HG. Mitochondria isolated from myocardium subjected to IPC required significantly higher in vitro Ca(2+) concentrations (184 ± 14 µmol mg(-1) protein) to open the mitochondrial permeability transition pore when compared with mitochondria isolated from control experiments (142 ± 10 µmol mg(-1) protein). This beneficial effect of IPC was reversed by HG and rescued by GTPCH-1 overexpression. CONCLUSION: Increased BH(4) by cardiomyocyte-specific overexpression of GTPCH-1 preserves the ability of IPC to elicit myocardial and mitochondrial protection that is impaired by HG, and this action appears to be dependent on NO.
AIMS: Hyperglycaemia (HG) decreases intracellular tetrahydrobiopterin (BH(4)) concentrations, and this action may contribute to injury during myocardial ischaemia and reperfusion. We investigated whether increased BH(4) by cardiomyocyte-specific overexpression of the GTP cyclohydrolase (GTPCH) 1 gene rescues myocardial and mitochondrial protection by ischaemic preconditioning (IPC) during HG through a nitric oxide (NO)-dependent pathway. METHODS AND RESULTS:Mice underwent 30 min of myocardial ischaemia followed by 2 h of reperfusion with or without IPC elicited with four cycles of 5 min ischaemia/5 min of reperfusion in the presence or absence of HG produced by d-glucose. In C57BL/6 wild-type mice, IPC increased myocardial BH(4) and NO concentrations and decreased myocardial infarct size (30 ± 3% of risk area) compared with control (56 ± 5%) experiments. This protective effect was inhibited by HG (48 ± 3%) but not hyperosmolarity. GTPCH-1 overexpression increased myocardial BH(4) and NO concentrations and restored cardioprotection by IPC during HG (32 ± 4%). In contrast, a non-selective NO synthase inhibitor N(G)-nitro-l-arginine methyl ester attenuated the favourable effects of GTPCH-1 overexpression (52 ± 3%) during HG. Mitochondria isolated from myocardium subjected to IPC required significantly higher in vitro Ca(2+) concentrations (184 ± 14 µmol mg(-1) protein) to open the mitochondrial permeability transition pore when compared with mitochondria isolated from control experiments (142 ± 10 µmol mg(-1) protein). This beneficial effect of IPC was reversed by HG and rescued by GTPCH-1 overexpression. CONCLUSION: Increased BH(4) by cardiomyocyte-specific overexpression of GTPCH-1 preserves the ability of IPC to elicit myocardial and mitochondrial protection that is impaired by HG, and this action appears to be dependent on NO.
Authors: J R Kersten; M W Montgomery; T Ghassemi; E R Gross; W G Toller; P S Pagel; D C Warltier Journal: Am J Physiol Heart Circ Physiol Date: 2001-04 Impact factor: 4.733
Authors: Subodh Verma; Andrew Maitland; Richard D Weisel; Paul W M Fedak; Neil C Pomroy; Shu-Hong Li; Donald A G Mickle; Ren-Ke Li; Vivek Rao Journal: J Thorac Cardiovasc Surg Date: 2002-06 Impact factor: 5.209
Authors: Cristian Dumitrescu; Roberto Biondi; Yong Xia; Arturo J Cardounel; Lawrence J Druhan; Giuseppe Ambrosio; Jay L Zweier Journal: Proc Natl Acad Sci U S A Date: 2007-09-11 Impact factor: 11.205
Authors: Nikolina Vladic; Zhi-Dong Ge; Thorsten Leucker; Anna K Brzezinska; Jian-Hai Du; Yang Shi; David C Warltier; Phillip F Pratt; Judy R Kersten Journal: Am J Physiol Heart Circ Physiol Date: 2011-09-09 Impact factor: 4.733
Authors: Shigang Qiao; Jessica M Olson; Mark Paterson; Yasheng Yan; Ivan Zaja; Yanan Liu; Matthias L Riess; Judy R Kersten; Mingyu Liang; David C Warltier; Zeljko J Bosnjak; Zhi-Dong Ge Journal: Anesthesiology Date: 2015-10 Impact factor: 7.892
Authors: Shelley L Baumgardt; Mark Paterson; Thorsten M Leucker; Juan Fang; David X Zhang; Zeljko J Bosnjak; David C Warltier; Judy R Kersten; Zhi-Dong Ge Journal: Circ Heart Fail Date: 2016-01 Impact factor: 8.790
Authors: Savitha Sethumadhavan; Jennifer Whitsett; Brian Bennett; Irina A Ionova; Galen M Pieper; Jeannette Vasquez-Vivar Journal: Free Radic Biol Med Date: 2016-01-27 Impact factor: 7.376
Authors: Jennifer K Bendall; Gillian Douglas; Eileen McNeill; Keith M Channon; Mark J Crabtree Journal: Antioxid Redox Signal Date: 2014-03-14 Impact factor: 8.401